Skip to content

TExT-MED + FANS Full Trial

Trial to EXamine Text Messaging for Diabetes in ED Patients Incorporating Social Support - Intervention With Washout

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03178773
Acronym
TExTMED+FANSII
Enrollment
166
Registered
2017-06-07
Start date
2017-07-18
Completion date
2019-12-02
Last updated
2021-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Keywords

mobile health, social support, health disparity, Latino

Brief summary

This is an intervention to study incorporating social support into mHealth interventions for low-income, ED patients with diabetes

Detailed description

Diabetes has disproportionately affected the Latino population. TExT-MED (Trial to Examine Text Message for Emergency Department Patients with Diabetes) is a locally designed, successful mobile health (mHealth) intervention for low income Latinos with diabetes. Social support interventions have likewise been successful at improving patient self-efficacy and disease management but are limited in scale due to two key obstacles: 1) requirements of in-person training of family and friends to be supporters and 2) the need to coordinate schedules and physical location between the patient and their supporter. mHealth can overcome these obstacles by allowing supporters to be trained remotely via a mobile platform and by allowing communication between a patient and supporter to occur at any time or place. The proposed intervention leverages the success of TExT-MED by augmenting the program with a social supporter that each patient can select from his or her own social support system (Family And friend Network Supporters (FANS)), creating TExT-MED+FANS. This is a 12 month, randomized study of this intervention. At the completion of the trial, we will evaluate the user experience with TExT-MED+FANS, and the impact of TExT-MED+FANS on patient motivation, self-efficacy and behaviors through a qualitative analysis of semi-structured individual interviews.

Interventions

BEHAVIORALTExT-MED

messages designed to inspire motivation and behavior change

BEHAVIORALFANS

SMS delivered messages to family members to improve social support

Sponsors

University of Southern California
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \>18 * HbA1c\>8.5 * Social support person identified and contacted

Exclusion criteria

* unable to consent * does not speak/read English or Spanish

Design outcomes

Primary

MeasureTime frameDescription
Change in HBA1c From Baseline6 MonthsGlycemic control is measured by hemoglobin A1C collected at point-of-care from an Afinion AS100 capillary point of care machine. The Afinion machine has excellent point of care correlation with laboratory values. As a surrogate for average glycemic control over the previous 3 months and with correlation with clinical outcomes, hemoglobin A1c is a marker of overall clinical disease management. Change is baseline value minus follow up value.

Secondary

MeasureTime frameDescription
Change in BMI From Baseline6 MonthsCalculated from Weight and Height. As a measure of adiposity, it correlates positively with cardiovascular disease outcomes. While imperfect, it is an easily measured and validated marker.
Change in BMI From 6 Months to 12 Months12 MonthsCalculated from Weight and Height. As a measure of adiposity, it correlates positively with cardiovascular disease outcomes. While imperfect, it is an easily measured and validated marker.
Change in Abdominal Circumference From Baseline6 MonthsA measure of central adiposity, it correlates with cardiovascular outcomes.
Change From Abdominal Circumference From 6 Months to 12 Months12 MonthsA measure of central adiposity, it correlates with cardiovascular outcomes.
Change in Systolic Blood Pressure From Baseline6 MonthsBlood pressure is measured by study RAs after the patient is seated for 5 minutes, with the average of three readings used as the systolic blood pressure for that visit. Systolic blood pressure is associated with cardiovascular complications
Change in Systolic Blood Pressure From 6 Months to 12 Months12 MonthsBlood pressure is measured by study RAs after the patient is seated for 5 minutes, with the average of three readings used as the systolic blood pressure for that visit. Systolic blood pressure is associated with cardiovascular complications
Change in Diastolic Blood Pressure From Baseline6 MonthsBlood pressure is measured by study RAs after the patient is seated for 5 minutes, with the average of three readings used as the diastolic blood pressure for that visit.
Change in Diastolic Blood Pressure From 6 Months to 12 Months12 MonthsBlood pressure is measured by study RAs after the patient is seated for 5 minutes, with the average of three readings used as the diastolic blood pressure for that visit.
Change in Summary of Diabetes Self-care Activities From Baseline6 MonthsSummary of Diabetes Self-care Activities (Toobert, Hampson, Glasgow, & RE, 2000). The Summary consists of 6 subscales representing different domains of diabetes related healthy behaviors and self-care. It has been validated in over 10 studies, with the results published in two manuscripts: one with three studies (Toobert & Glasgow, 1994), and one with seven studies(Toobert et al., 2000). Each measure ranges from Each range from 0-7, indicating number of days per week patient reports engaging in these behaviors.
Change in Summary of Diabetes Self-care Activities From 6 Months to 12 Months12 MonthsSummary of Diabetes Self-care Activities (Toobert, Hampson, Glasgow, & RE, 2000). The Summary consists of 6 subscales representing different domains of diabetes related healthy behaviors and self-care. It has been validated in over 10 studies, with the results published in two manuscripts: one with three studies (Toobert & Glasgow, 1994), and one with seven studies(Toobert et al., 2000). Each measure ranges from Each range from 0-7, indicating number of days per week patient reports engaging in these behaviors.
Change in Wilson 3 Item Scale From Baseline6 MonthsMedication adherence(Wilson et al.,2014). The 3item medication adherence scale is a self-report measure that assessing no. of days medication missed in prior month, days taken medication as advised & self-rated medication adherence. Developed in HIV research, it has been validated for non-HIV medications (Wilson, et al,2016). Each component contributes 33% of the scale. Total score ranges from 0-100. It is the combination of 3 sub-scores, (days missed dose(negative scored), self-rating, days taking medications as indicated). Higher scores indicate better medication adherence.
Change in Wilson 3 Item Scale From 6 Months to 12 Months12 MonthsMedication adherence(Wilson et al.,2014). The 3item medication adherence scale is a self-report measure that assessing no. of days medication missed in prior month, days taken medication as advised & self-rated medication adherence. Developed in HIV research, it has been validated for non-HIV medications (Wilson, et al,2016). Each component contributes 33% of the scale. Total score ranges from 0-100. It is the combination of 3 sub-scores, (days missed dose(negative scored), self-rating, days taking medications as indicated). Higher scores indicate better medication adherence.
Change in Healthcare Utilization From Baseline6 MonthsHealthcare utilization by EMR review of clinic appointments, ED visits and hospitalizations within enrollment through 6 months at each follow up visit.
Change in Healthcare Utilization From 6 Months to 12 Months12 MonthsHealthcare utilization by EMR review of clinic appointments, ED visits and hospitalizations within enrollment through 6 months at each follow up visit.
Change in Diabetes Empowerment Scale Short Form From Baseline6 MonthsChange in Self-efficacy. Diabetes Empowerment Scale Short Form (Anderson, Fitzgerald, Gruppen, Funnell, & Oh, 2003), is a measure of a patient's overall diabetes related self-efficacy, shortened by the original from 37 to an 8 item scale. It has reliability of alpha=0.84; and has been shown to be sensitive to change in multiple populations and is correlated with improved glycemic control measured by A1C (Anderson et al., 2003). It ranges from 8-40 points; higher score indicates higher self-efficacy.
Change in Diabetes Empowerment Scale Short Form From 6 Months to 12 Months12 monthsChange in Self-efficacy. Diabetes Empowerment Scale Short Form (Anderson, Fitzgerald, Gruppen, Funnell, & Oh, 2003), is a measure of a patient's overall diabetes related self-efficacy, shortened by the original from 37 to an 8 item scale. It has reliability of alpha=0.84; and has been shown to be sensitive to change in multiple populations and is correlated with improved glycemic control measured by A1C (Anderson et al., 2003). It ranges from 8-40 points; higher score indicates higher self-efficacy.
Change in HBA1c From 6 Months to 12 Months12 monthsGlycemic control is measured by hemoglobin A1C collected at point-of-care from an Afinion AS100 capillary point of care machine. The Afinion machine has excellent point of care correlation with laboratory values. As a surrogate for average glycemic control over the previous 3 months and with correlation with clinical outcomes, hemoglobin A1c is a marker of overall clinical disease management. Change is 6 month value minus 12 month value.
Change in Diabetes Distress Scale From 6 Months to 12 Months12 MonthsDiabetes related distress (Diabetes Distress Scale) (Polonsky et al., 2005), is a 17 item scale measuring distress related to emotional burden, physician-related distress, regimen-related distress, and diabetes-related interpersonal issues. It has a Cronbach's alpha of 0.88-0.93 in various studies. Higher scores are negatively correlated with several healthy behaviors. Each question is a Likert scale ranking of how serious a particular issue is from 1-6, 6 indicating a more significant problem. The scores are then averaged across all item, with final scores ranging from 1-6, with 6 indicating higher levels of distress
Change in Patient Health Questionnaire 9 From Baseline6 MonthsDepression as measured by the PHQ-9 (Kroenke, Spitzer, Williams, & Lowe, 2010), is a widely used scale of depression used in clinical practice and research. The Cronbach's alpha ranges from 0.86-0.89, and it has been validated in multiple languages. Depression is worse with higher scores. Score ranges from 0 to 27. Higher levels of depression are associated with fewer healthy behaviors and worse glycemic control.
Change in Patient Health Questionnaire 9 From 6 Months to 12 Months12 MonthsDepression as measured by the PHQ-9 (Kroenke, Spitzer, Williams, & Lowe, 2010), is a widely used scale of depression used in clinical practice and research. The Cronbach's alpha ranges from 0.86-0.89, and it has been validated in multiple languages. Depression is worse with higher scores. Score ranges from 0 to 27. Higher levels of depression are associated with fewer healthy behaviors and worse glycemic control.
Change in Fatalism From Baseline6 MonthsFatalism is measured by the Diabetes Fatalism Scale (Egede & Ellis, 2010), which measures three subscale emotional distress, religiosity and coping and perceived self-efficacy, which are summed together. The total score ranges from 12-72, higher score indicates higher fatalism, and has a Cronbach's alpha of 0.80. The score is associated with glycemic control, depression, self-care behaviors and social factors.
Change in Fatalism From 6 Months to 12 Months12 MonthsFatalism is measured by the Diabetes Fatalism Scale (Egede & Ellis, 2010), which measures three subscale emotional distress, religiosity and coping and perceived self-efficacy, which are summed together. The total score ranges from 12-72, higher score indicates higher fatalism, and has a Cronbach's alpha of 0.80. The score is associated with glycemic control, depression, self-care behaviors and social factors.
Change in WHO Quality of Life From Baseline6 MonthsQuality of life (World Health Organization WHO-5 Well Being Index) (Topp, Ostergaard, Sondergaard, & Bech, 2015) is a widely used measure of quality life, validated in many languages and consists of only 5 items. Each self-reported item is scored between 0 and 5, summed together and then multiplied by 4. The total range is from 0 to 100, with 0 being the lowest quality of life.
Change in WHO Quality of Life From 6 Months to 12 Months12 MonthsQuality of life (World Health Organization WHO-5 Well Being Index) (Topp, Ostergaard, Sondergaard, & Bech, 2015) is a widely used measure of quality life, validated in many languages and consists of only 5 items. Each self-reported item is scored between 0 and 5, summed together and then multiplied by 4. The total range is from 0 to 100, with 0 being the lowest quality of life.
Change in Diabetes Family Behavior Checklist - Supportive From Baseline6 MonthsDiabetes-related supportive and obstructive family behaviors are measured by patient report on the Diabetes Family Behavior checklist (Lewin et al., 2005). Family behaviors: supportive and non-supportive sub-scores of the Diabetes Family Behavior Checklist: supportive ranges from 4-45 (4 being lowest in family supportive behavior), non-supportive ranges from 7-35 (4 indicating least report of non-supportive behavior). Non-supportive scores are subtracted form supportive scores for a total.
Change in Diabetes Family Behavior Checklist Supportive From 6 Months to 12 Months12 MonthsDiabetes-related supportive and obstructive family behaviors are measured by patient report on the Diabetes Family Behavior checklist (Lewin et al., 2005). Family behaviors: supportive and non-supportive sub-scores of the Diabetes Family Behavior Checklist: supportive ranges from 4-45 (4 being lowest in family supportive behavior), non-supportive ranges from 7-35 (4 indicating least report of non-supportive behavior). Non-supportive scores are subtracted form supportive scores for a total.
Change in Diabetes Family Behavior Checklist - Nonsupportive From Baseline6 MonthsDiabetes-related supportive and obstructive family behaviors are measured by patient report on the Diabetes Family Behavior checklist (Lewin et al., 2005). Family behaviors: supportive and non-supportive sub-scores of the Diabetes Family Behavior Checklist: supportive ranges from 4-45 (4 being lowest in family supportive behavior), non-supportive ranges from 7-35 (4 indicating least report of non-supportive behavior). Non-supportive scores are subtracted form supportive scores for a total.
Change in Diabetes Family Behavior Checklist Nonsupportive From 6 Months to 12 Months12 MonthsDiabetes-related supportive and obstructive family behaviors are measured by patient report on the Diabetes Family Behavior checklist (Lewin et al., 2005). Family behaviors: supportive and non-supportive sub-scores of the Diabetes Family Behavior Checklist: supportive ranges from 4-45 (4 being lowest in family supportive behavior), non-supportive ranges from 7-35 (4 indicating least report of non-supportive behavior). Non-supportive scores are subtracted form supportive scores for a total.
Change in Diabetes Care Profile Support From Baseline6 MonthsDiabetes-specific social support is measured by the Diabetes Care Profile Support Questions,(Fitzgerald et al., 1996) with sub-scores for perceived disease specific support needs and perceived disease specific support received. Diabetes Care Profile support questions: Support wanted, and support received. Each range from 5 to 30, high scores indicating high desire for support and higher support received.
Change in Diabetes Care Profile Support From 6 Months to 12 Months12 MonthsDiabetes-specific social support is measured by the Diabetes Care Profile Support Questions,(Fitzgerald et al., 1996) with sub-scores for perceived disease specific support needs and perceived disease specific support received. Diabetes Care Profile support questions: Support wanted, and support received. Each range from 5 to 30, high scores indicating high desire for support and higher support received.
Change in Norbeck Social Support Questionnaire From Baseline6 MonthsMeasure Description: General social support is captured by the Norbeck Social Support Questionnaire Emotional and&Tangible subscales.(Norbeck, Lindsey, & Carrieri, 1981) General social support: Norbeck Social Support Questionnaire, emotional sub score (ranges 0-16, with higher scores indicating higher perceived emotional support) & tangible sub score (0-8, higher score indicating higher perceived tangible support). While the subscores are highly correlated, the authors do not recommend Cronbach's alpha as a test of internal validity.(http://eileengigliotti.com/uploads/1/1/0/2/110241155/nssq-psychometric.pdf)
Change in Norbeck Social Support Questionnaire From 6 Months to 12 Months12 MonthsMeasure Description: General social support is captured by the Norbeck Social Support Questionnaire Emotional and&Tangible subscales.(Norbeck, Lindsey, & Carrieri, 1981) General social support: Norbeck Social Support Questionnaire, emotional sub score (ranges 0-16, with higher scores indicating higher perceived emotional support) & tangible sub score (0-8, higher score indicating higher perceived tangible support). While the subscores are highly correlated, the authors do not recommend Cronbach's alpha as a test of internal validity.(http://eileengigliotti.com/uploads/1/1/0/2/110241155/nssq-psychometric.pdf)
Change in Partner Distress Scale From Baseline6 MonthsSupporter diabetes-related distress is measured by the Partner Distress Scale (Polonsky, Fisher, Hessler, &Johnson, 2016). The self-report scale consists of 21 items in 4 domains: my partner's diabetes management, how best to help, diabetes & me, & hypoglycemia. Domains are summed together. Each item is score from 0 to 4, lower scores indicate less distress. The total score is an average of the 21 items. The Cronbach's alpha was 0.76 for total scores. Greater partner distress is correlated with higher A1C among patients, worse self-care & lower satisfaction with relationship
Change in Diabetes Distress Scale From Baseline6 MonthsDiabetes related distress (Diabetes Distress Scale) (Polonsky et al., 2005), is a 17 item scale measuring distress related to emotional burden, physician-related distress, regimen-related distress, and diabetes-related interpersonal issues. It has a Cronbach's alpha of 0.88-0.93 in various studies. Higher scores are negatively correlated with several healthy behaviors. Each question is a Likert scale ranking of how serious a particular issue is from 1-6, 6 indicating a more significant problem. The scores are then averaged across all item, with final scores ranging from 1-6, with 6 indicating higher levels of distress

Countries

United States

Participant flow

Participants by arm

ArmCount
TExT-MED Only
Patients receive SMS-textmessage curriculum to improve self0-efficacy and self care for diabetes. A patient-identified family member receives a social support curriculum (FANS) in traditional booklet form. TExT-MED: messages designed to inspire motivation and behavior change
86
TExT-MED+FANS
Patients receive SMS-textmessage curriculum to improve self0-efficacy and self care for diabetes. A patient-identified family member receives a social support curriculum (FANS) by SMS-text-message synchronized by time and content. TExT-MED: messages designed to inspire motivation and behavior change FANS: SMS delivered messages to family members to improve social support
80
Total166

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyDeath01
Overall StudyLost to Follow-up2925
Overall StudyWithdrawal by Subject1014

Baseline characteristics

CharacteristicTotalTExT-MED OnlyTExT-MED+FANS
Abdominal circumference (cm)122.90 cm
STANDARD_DEVIATION 128.63
138.67 cm
STANDARD_DEVIATION 174.29
104.82 cm
STANDARD_DEVIATION 16.61
Age, Continuous48.9 years50.7 years47.7 years
BMI30.07 kg^m2
STANDARD_DEVIATION 7.6
30.78 kg^m2
STANDARD_DEVIATION 7.96
29.34 kg^m2
STANDARD_DEVIATION 7.18
Born outside US131 Participants75 Participants56 Participants
Diabetes Care Profile Support
Perceived Disease Specific Support Needs
23.61 units on a scale
STANDARD_DEVIATION 7.52
23.22 units on a scale
STANDARD_DEVIATION 7.51
24.04 units on a scale
STANDARD_DEVIATION 7.55
Diabetes Care Profile Support
Perceived Disease Specific Support Received
18.51 units on a scale
STANDARD_DEVIATION 8.92
17.91 units on a scale
STANDARD_DEVIATION 8.81
19.16 units on a scale
STANDARD_DEVIATION 9.06
Diabetes Care Profile Support
Support Attitudes
6.49 units on a scale
STANDARD_DEVIATION 5.11
6.58 units on a scale
STANDARD_DEVIATION 5.5
6.39 units on a scale
STANDARD_DEVIATION 4.68
Diabetes Distress Scale2.46 units on a scale
STANDARD_DEVIATION 0.1
2.32 units on a scale
STANDARD_DEVIATION 0.86
2.60 units on a scale
STANDARD_DEVIATION 1.11
Diabetes Empowerment Scale Short Form30.78 units on a scale
STANDARD_DEVIATION 5.28
30.50 units on a scale
STANDARD_DEVIATION 5.56
31.09 units on a scale
STANDARD_DEVIATION 4.99
Diabetes Family Behavior Checklist
Non-Supportive
18.75 units on a scale
STANDARD_DEVIATION 7.22
18.27 units on a scale
STANDARD_DEVIATION 7.23
19.28 units on a scale
STANDARD_DEVIATION 7.22
Diabetes Family Behavior Checklist
Supportive
24.09 units on a scale
STANDARD_DEVIATION 9.2
23.65 units on a scale
STANDARD_DEVIATION 9.12
24.56 units on a scale
STANDARD_DEVIATION 9.32
Diastolic blood pressure80.77 mmHg
STANDARD_DEVIATION 15.95
79.98 mmHg
STANDARD_DEVIATION 15.81
81.61 mmHg
STANDARD_DEVIATION 16.15
Ethnicity (NIH/OMB)
Hispanic or Latino
156 Participants82 Participants74 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
9 Participants3 Participants6 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants1 Participants0 Participants
Fatalism34.94 units on a scale
STANDARD_DEVIATION 9.89
34.09 units on a scale
STANDARD_DEVIATION 9.9
35.86 units on a scale
STANDARD_DEVIATION 9.85
HbA1c10.4 % percentage of hemoglobin glycosylated10.3 % percentage of hemoglobin glycosylated10.6 % percentage of hemoglobin glycosylated
Healthcare Utilization
Clinic Visits Made
3.02 Number of Healthcare Encounters
STANDARD_DEVIATION 5.43
3.28 Number of Healthcare Encounters
STANDARD_DEVIATION 5.61
2.74 Number of Healthcare Encounters
STANDARD_DEVIATION 5.25
Healthcare Utilization
ED/UCC Visits
2.42 Number of Healthcare Encounters
STANDARD_DEVIATION 2.74
2.45 Number of Healthcare Encounters
STANDARD_DEVIATION 2.12
2.38 Number of Healthcare Encounters
STANDARD_DEVIATION 3.29
Healthcare Utilization
Hospitalization
0.43 Number of Healthcare Encounters
STANDARD_DEVIATION 0.79
0.43 Number of Healthcare Encounters
STANDARD_DEVIATION 0.8
0.44 Number of Healthcare Encounters
STANDARD_DEVIATION 0.78
Language Preferred
English
50 Participants22 Participants28 Participants
Language Preferred
Spanish
116 Participants64 Participants52 Participants
Norbeck Social Support Questionnaire
Emotional
13.84 units on a scale
STANDARD_DEVIATION 3.23
14.00 units on a scale
STANDARD_DEVIATION 3.32
13.68 units on a scale
STANDARD_DEVIATION 3.15
Norbeck Social Support Questionnaire
Tangible
6.99 units on a scale
STANDARD_DEVIATION 1.68
6.83 units on a scale
STANDARD_DEVIATION 1.77
7.15 units on a scale
STANDARD_DEVIATION 1.57
Partner Distress Scale - Total1.42 units on a scale
STANDARD_DEVIATION 0.95
1.32 units on a scale
STANDARD_DEVIATION 0.94
1.52 units on a scale
STANDARD_DEVIATION 0.95
Patient Health Questionnaire 99.16 units on a scale
STANDARD_DEVIATION 6.63
8.90 units on a scale
STANDARD_DEVIATION 6.94
9.45 units on a scale
STANDARD_DEVIATION 6.31
Race (NIH/OMB)
American Indian or Alaska Native
5 Participants2 Participants3 Participants
Race (NIH/OMB)
Asian
2 Participants2 Participants0 Participants
Race (NIH/OMB)
Black or African American
9 Participants3 Participants6 Participants
Race (NIH/OMB)
More than one race
3 Participants2 Participants1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
73 Participants37 Participants36 Participants
Race (NIH/OMB)
White
74 Participants40 Participants34 Participants
Region of Enrollment
United States
166 participants86 participants80 participants
Sex: Female, Male
Female
84 Participants49 Participants35 Participants
Sex: Female, Male
Male
82 Participants37 Participants45 Participants
Summary of Diabetes Self-Care Activities
Checking feet daily for wounds
4.06 units on a scale
STANDARD_DEVIATION 2.93
4.01 units on a scale
STANDARD_DEVIATION 3
4.11 units on a scale
STANDARD_DEVIATION 2.86
Summary of Diabetes Self-Care Activities
Following a disease specific diet plan
3.87 units on a scale
STANDARD_DEVIATION 1.9
3.98 units on a scale
STANDARD_DEVIATION 1.9
3.74 units on a scale
STANDARD_DEVIATION 1.89
Summary of Diabetes Self-Care Activities
Following a generally healthy diet
3.23 units on a scale
STANDARD_DEVIATION 2.47
3.38 units on a scale
STANDARD_DEVIATION 2.44
3.07 units on a scale
STANDARD_DEVIATION 2.51
Summary of Diabetes Self-Care Activities
Getting sufficient physical activity
2.47 units on a scale
STANDARD_DEVIATION 2.57
2.51 units on a scale
STANDARD_DEVIATION 2.62
2.43 units on a scale
STANDARD_DEVIATION 2.53
Summary of Diabetes Self-Care Activities
Self-monitoring blood glucose as advised by a h
2.65 units on a scale
STANDARD_DEVIATION 2.92
2.55 units on a scale
STANDARD_DEVIATION 2.79
2.76 units on a scale
STANDARD_DEVIATION 3.06
Summary of Diabetes Self-Care Activities
Spacing carbohydrates throughout the day
2.89 units on a scale
STANDARD_DEVIATION 2.56
2.78 units on a scale
STANDARD_DEVIATION 2.65
3.00 units on a scale
STANDARD_DEVIATION 2.46
Systolic Blood Pressure131.30 mmHg
STANDARD_DEVIATION 26.88
131.55 mmHg
STANDARD_DEVIATION 25.02
131.03 mmHg
STANDARD_DEVIATION 28.9
WHO Quality of life60.02 units on a scale
STANDARD_DEVIATION 28
61.91 units on a scale
STANDARD_DEVIATION 26.59
58.00 units on a scale
STANDARD_DEVIATION 29.48
Wilson 3 Item Scale66.53 units on a scale
STANDARD_DEVIATION 29.67
67.16 units on a scale
STANDARD_DEVIATION 31.13
65.85 units on a scale
STANDARD_DEVIATION 28.23

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 861 / 80
other
Total, other adverse events
0 / 860 / 80
serious
Total, serious adverse events
21 / 8619 / 80

Outcome results

Primary

Change in HBA1c From Baseline

Glycemic control is measured by hemoglobin A1C collected at point-of-care from an Afinion AS100 capillary point of care machine. The Afinion machine has excellent point of care correlation with laboratory values. As a surrogate for average glycemic control over the previous 3 months and with correlation with clinical outcomes, hemoglobin A1c is a marker of overall clinical disease management. Change is baseline value minus follow up value.

Time frame: 6 Months

Population: 2 of the HbA1c were collected from electronic healthcare records in the active control group. 1 intervention group patient refused blood draw at follow up.

ArmMeasureValue (MEAN)
TExT-MED OnlyChange in HBA1c From Baseline1.42 %mmHg/dL
TExT-MED+FANSChange in HBA1c From Baseline1.34 %mmHg/dL
Secondary

Change From Abdominal Circumference From 6 Months to 12 Months

A measure of central adiposity, it correlates with cardiovascular outcomes.

Time frame: 12 Months

Population: abdominal circumference not measured in 9 participants

ArmMeasureValue (MEAN)Dispersion
TExT-MED OnlyChange From Abdominal Circumference From 6 Months to 12 Months0.99 cmStandard Deviation 5.1
TExT-MED+FANSChange From Abdominal Circumference From 6 Months to 12 Months0.85 cmStandard Deviation 18.51
TotalChange From Abdominal Circumference From 6 Months to 12 Months0.93 cmStandard Deviation 12.7
Secondary

Change in Abdominal Circumference From Baseline

A measure of central adiposity, it correlates with cardiovascular outcomes.

Time frame: 6 Months

Population: abdominal circumference unable to be collected from 20 patients

ArmMeasureValue (MEAN)Dispersion
TExT-MED OnlyChange in Abdominal Circumference From Baseline1.58 cmStandard Deviation 14.7
TExT-MED+FANSChange in Abdominal Circumference From Baseline2.73 cmStandard Deviation 22.54
TotalChange in Abdominal Circumference From Baseline2.11 cmStandard Deviation 18.62
Secondary

Change in BMI From 6 Months to 12 Months

Calculated from Weight and Height. As a measure of adiposity, it correlates positively with cardiovascular disease outcomes. While imperfect, it is an easily measured and validated marker.

Time frame: 12 Months

Population: 5 participants unable stand to provide weight

ArmMeasureValue (MEAN)Dispersion
TExT-MED OnlyChange in BMI From 6 Months to 12 Months-3.38 kg^m2Standard Deviation 22.51
TExT-MED+FANSChange in BMI From 6 Months to 12 Months4.02 kg^m2Standard Deviation 24.88
TotalChange in BMI From 6 Months to 12 Months-0.04 kg^m2Standard Deviation 23.75
Secondary

Change in BMI From Baseline

Calculated from Weight and Height. As a measure of adiposity, it correlates positively with cardiovascular disease outcomes. While imperfect, it is an easily measured and validated marker.

Time frame: 6 Months

Population: 4 participants were not able to stand on the scale to measure weight

ArmMeasureValue (MEAN)Dispersion
TExT-MED OnlyChange in BMI From Baseline-7.91 kg^m2Standard Deviation 33.8
TExT-MED+FANSChange in BMI From Baseline-3.84 kg^m2Standard Deviation 22.94
TotalChange in BMI From Baseline-5.96 kg^m2Standard Deviation 29.03
Secondary

Change in Diabetes Care Profile Support From 6 Months to 12 Months

Diabetes-specific social support is measured by the Diabetes Care Profile Support Questions,(Fitzgerald et al., 1996) with sub-scores for perceived disease specific support needs and perceived disease specific support received. Diabetes Care Profile support questions: Support wanted, and support received. Each range from 5 to 30, high scores indicating high desire for support and higher support received.

Time frame: 12 Months

ArmMeasureGroupValue (MEAN)Dispersion
TExT-MED OnlyChange in Diabetes Care Profile Support From 6 Months to 12 MonthsPerceived Disease Specific Support Needs-0.38 units on a scaleStandard Deviation 8.17
TExT-MED OnlyChange in Diabetes Care Profile Support From 6 Months to 12 MonthsPerceived Disease Specific Support Received-1.38 units on a scaleStandard Deviation 7.54
TExT-MED OnlyChange in Diabetes Care Profile Support From 6 Months to 12 MonthsSupport Attitudes-0.77 units on a scaleStandard Deviation 4.56
TExT-MED+FANSChange in Diabetes Care Profile Support From 6 Months to 12 MonthsPerceived Disease Specific Support Received2.70 units on a scaleStandard Deviation 8.17
TExT-MED+FANSChange in Diabetes Care Profile Support From 6 Months to 12 MonthsPerceived Disease Specific Support Needs0.40 units on a scaleStandard Deviation 10.31
TExT-MED+FANSChange in Diabetes Care Profile Support From 6 Months to 12 MonthsSupport Attitudes0.08 units on a scaleStandard Deviation 4.01
TotalChange in Diabetes Care Profile Support From 6 Months to 12 MonthsSupport Attitudes-0.38 units on a scaleStandard Deviation 4.31
TotalChange in Diabetes Care Profile Support From 6 Months to 12 MonthsPerceived Disease Specific Support Needs-0.02 units on a scaleStandard Deviation 9.17
TotalChange in Diabetes Care Profile Support From 6 Months to 12 MonthsPerceived Disease Specific Support Received0.49 units on a scaleStandard Deviation 8.06
Secondary

Change in Diabetes Care Profile Support From Baseline

Diabetes-specific social support is measured by the Diabetes Care Profile Support Questions,(Fitzgerald et al., 1996) with sub-scores for perceived disease specific support needs and perceived disease specific support received. Diabetes Care Profile support questions: Support wanted, and support received. Each range from 5 to 30, high scores indicating high desire for support and higher support received.

Time frame: 6 Months

Population: 2 participants in active control arm did not attend follow up visit. Hba1c taken from medical records, no other data available.

ArmMeasureGroupValue (MEAN)Dispersion
TExT-MED OnlyChange in Diabetes Care Profile Support From BaselinePerceived Disease Specific Support Needs4.44 units on a scaleStandard Error 10.79
TExT-MED OnlyChange in Diabetes Care Profile Support From BaselinePerceived Disease Specific Support Received-0.08 units on a scaleStandard Error 9.68
TExT-MED OnlyChange in Diabetes Care Profile Support From BaselineSupport Attitudes0.96 units on a scaleStandard Error 6.51
TExT-MED+FANSChange in Diabetes Care Profile Support From BaselinePerceived Disease Specific Support Received-3.65 units on a scaleStandard Error 9.11
TExT-MED+FANSChange in Diabetes Care Profile Support From BaselineSupport Attitudes-0.87 units on a scaleStandard Error 5.73
TExT-MED+FANSChange in Diabetes Care Profile Support From BaselinePerceived Disease Specific Support Needs5.80 units on a scaleStandard Error 9.06
TotalChange in Diabetes Care Profile Support From BaselinePerceived Disease Specific Support Needs5.08 units on a scaleStandard Error 9.99
TotalChange in Diabetes Care Profile Support From BaselineSupport Attitudes0.10 units on a scaleStandard Error 6.2
TotalChange in Diabetes Care Profile Support From BaselinePerceived Disease Specific Support Received-1.76 units on a scaleStandard Error 9.54
Secondary

Change in Diabetes Distress Scale From 6 Months to 12 Months

Diabetes related distress (Diabetes Distress Scale) (Polonsky et al., 2005), is a 17 item scale measuring distress related to emotional burden, physician-related distress, regimen-related distress, and diabetes-related interpersonal issues. It has a Cronbach's alpha of 0.88-0.93 in various studies. Higher scores are negatively correlated with several healthy behaviors. Each question is a Likert scale ranking of how serious a particular issue is from 1-6, 6 indicating a more significant problem. The scores are then averaged across all item, with final scores ranging from 1-6, with 6 indicating higher levels of distress

Time frame: 12 Months

ArmMeasureValue (MEAN)Dispersion
TExT-MED OnlyChange in Diabetes Distress Scale From 6 Months to 12 Months0.06 units on a scaleStandard Deviation 0.92
TExT-MED+FANSChange in Diabetes Distress Scale From 6 Months to 12 Months-0.01 units on a scaleStandard Deviation 0.71
TotalChange in Diabetes Distress Scale From 6 Months to 12 Months0.03 units on a scaleStandard Deviation 0.83
Secondary

Change in Diabetes Distress Scale From Baseline

Diabetes related distress (Diabetes Distress Scale) (Polonsky et al., 2005), is a 17 item scale measuring distress related to emotional burden, physician-related distress, regimen-related distress, and diabetes-related interpersonal issues. It has a Cronbach's alpha of 0.88-0.93 in various studies. Higher scores are negatively correlated with several healthy behaviors. Each question is a Likert scale ranking of how serious a particular issue is from 1-6, 6 indicating a more significant problem. The scores are then averaged across all item, with final scores ranging from 1-6, with 6 indicating higher levels of distress

Time frame: 6 Months

Population: 2 participants in active control arm did not attend follow up visit. Hba1c taken from medical records, no other data available.

ArmMeasureValue (MEAN)Dispersion
TExT-MED OnlyChange in Diabetes Distress Scale From Baseline0.65 units on a scaleStandard Deviation 0.97
TExT-MED+FANSChange in Diabetes Distress Scale From Baseline0.60 units on a scaleStandard Deviation 1.15
TotalChange in Diabetes Distress Scale From Baseline0.63 units on a scaleStandard Deviation 1.06
Secondary

Change in Diabetes Empowerment Scale Short Form From 6 Months to 12 Months

Change in Self-efficacy. Diabetes Empowerment Scale Short Form (Anderson, Fitzgerald, Gruppen, Funnell, & Oh, 2003), is a measure of a patient's overall diabetes related self-efficacy, shortened by the original from 37 to an 8 item scale. It has reliability of alpha=0.84; and has been shown to be sensitive to change in multiple populations and is correlated with improved glycemic control measured by A1C (Anderson et al., 2003). It ranges from 8-40 points; higher score indicates higher self-efficacy.

Time frame: 12 months

ArmMeasureValue (MEAN)Dispersion
TExT-MED OnlyChange in Diabetes Empowerment Scale Short Form From 6 Months to 12 Months0.13 units on a scaleStandard Deviation 0.49
TExT-MED+FANSChange in Diabetes Empowerment Scale Short Form From 6 Months to 12 Months-0.03 units on a scaleStandard Deviation 0.54
TotalChange in Diabetes Empowerment Scale Short Form From 6 Months to 12 Months0.05 units on a scaleStandard Deviation 0.52
Secondary

Change in Diabetes Empowerment Scale Short Form From Baseline

Change in Self-efficacy. Diabetes Empowerment Scale Short Form (Anderson, Fitzgerald, Gruppen, Funnell, & Oh, 2003), is a measure of a patient's overall diabetes related self-efficacy, shortened by the original from 37 to an 8 item scale. It has reliability of alpha=0.84; and has been shown to be sensitive to change in multiple populations and is correlated with improved glycemic control measured by A1C (Anderson et al., 2003). It ranges from 8-40 points; higher score indicates higher self-efficacy.

Time frame: 6 Months

Population: 2 participants in active control arm did not attend follow up visit. Hba1c taken from medical records, no other data available.

ArmMeasureValue (MEAN)Dispersion
TExT-MED OnlyChange in Diabetes Empowerment Scale Short Form From Baseline-0.17 units on a scaleStandard Deviation 0.63
TExT-MED+FANSChange in Diabetes Empowerment Scale Short Form From Baseline-0.05 units on a scaleStandard Deviation 0.69
TotalChange in Diabetes Empowerment Scale Short Form From Baseline-0.11 units on a scaleStandard Deviation 0.66
Secondary

Change in Diabetes Family Behavior Checklist Nonsupportive From 6 Months to 12 Months

Diabetes-related supportive and obstructive family behaviors are measured by patient report on the Diabetes Family Behavior checklist (Lewin et al., 2005). Family behaviors: supportive and non-supportive sub-scores of the Diabetes Family Behavior Checklist: supportive ranges from 4-45 (4 being lowest in family supportive behavior), non-supportive ranges from 7-35 (4 indicating least report of non-supportive behavior). Non-supportive scores are subtracted form supportive scores for a total.

Time frame: 12 Months

Population: patients who achieved follow up at 12 months

ArmMeasureValue (MEAN)Dispersion
TExT-MED OnlyChange in Diabetes Family Behavior Checklist Nonsupportive From 6 Months to 12 Months-.85 units on a scaleStandard Deviation 6.1
TExT-MED+FANSChange in Diabetes Family Behavior Checklist Nonsupportive From 6 Months to 12 Months-1.13 units on a scaleStandard Deviation 6.93
TotalChange in Diabetes Family Behavior Checklist Nonsupportive From 6 Months to 12 Months-.98 units on a scaleStandard Deviation 6.46
Secondary

Change in Diabetes Family Behavior Checklist - Nonsupportive From Baseline

Diabetes-related supportive and obstructive family behaviors are measured by patient report on the Diabetes Family Behavior checklist (Lewin et al., 2005). Family behaviors: supportive and non-supportive sub-scores of the Diabetes Family Behavior Checklist: supportive ranges from 4-45 (4 being lowest in family supportive behavior), non-supportive ranges from 7-35 (4 indicating least report of non-supportive behavior). Non-supportive scores are subtracted form supportive scores for a total.

Time frame: 6 Months

Population: 2 participants in active control arm did not attend follow up visit. Hba1c taken from medical records, no other data available.

ArmMeasureValue (MEAN)Dispersion
TExT-MED OnlyChange in Diabetes Family Behavior Checklist - Nonsupportive From Baseline.58 units on a scaleStandard Deviation 6.25
TExT-MED+FANSChange in Diabetes Family Behavior Checklist - Nonsupportive From Baseline.56 units on a scaleStandard Deviation 6.86
TotalChange in Diabetes Family Behavior Checklist - Nonsupportive From Baseline.57 units on a scaleStandard Deviation 6.51
Secondary

Change in Diabetes Family Behavior Checklist Supportive From 6 Months to 12 Months

Diabetes-related supportive and obstructive family behaviors are measured by patient report on the Diabetes Family Behavior checklist (Lewin et al., 2005). Family behaviors: supportive and non-supportive sub-scores of the Diabetes Family Behavior Checklist: supportive ranges from 4-45 (4 being lowest in family supportive behavior), non-supportive ranges from 7-35 (4 indicating least report of non-supportive behavior). Non-supportive scores are subtracted form supportive scores for a total.

Time frame: 12 Months

Population: patients who achieved follow up at 12 months

ArmMeasureValue (MEAN)Dispersion
TExT-MED OnlyChange in Diabetes Family Behavior Checklist Supportive From 6 Months to 12 Months-.70 units on a scaleStandard Deviation 7.87
TExT-MED+FANSChange in Diabetes Family Behavior Checklist Supportive From 6 Months to 12 Months-.98 units on a scaleStandard Deviation 9.32
TotalChange in Diabetes Family Behavior Checklist Supportive From 6 Months to 12 Months-.83 units on a scaleStandard Deviation 8.52
Secondary

Change in Diabetes Family Behavior Checklist - Supportive From Baseline

Diabetes-related supportive and obstructive family behaviors are measured by patient report on the Diabetes Family Behavior checklist (Lewin et al., 2005). Family behaviors: supportive and non-supportive sub-scores of the Diabetes Family Behavior Checklist: supportive ranges from 4-45 (4 being lowest in family supportive behavior), non-supportive ranges from 7-35 (4 indicating least report of non-supportive behavior). Non-supportive scores are subtracted form supportive scores for a total.

Time frame: 6 Months

Population: 2 participants in active control arm did not attend follow up visit. Hba1c taken from medical records, no other data available.

ArmMeasureValue (MEAN)Dispersion
TExT-MED OnlyChange in Diabetes Family Behavior Checklist - Supportive From Baseline.58 units on a scaleStandard Deviation 7.99
TExT-MED+FANSChange in Diabetes Family Behavior Checklist - Supportive From Baseline.12 units on a scaleStandard Deviation 9.08
TotalChange in Diabetes Family Behavior Checklist - Supportive From Baseline.36 units on a scaleStandard Deviation 8.48
Secondary

Change in Diastolic Blood Pressure From 6 Months to 12 Months

Blood pressure is measured by study RAs after the patient is seated for 5 minutes, with the average of three readings used as the diastolic blood pressure for that visit.

Time frame: 12 Months

Population: 11 patients with DBP unable to be obtained

ArmMeasureValue (MEAN)Dispersion
TExT-MED OnlyChange in Diastolic Blood Pressure From 6 Months to 12 Months-0.82 mmHgStandard Deviation 17.39
TExT-MED+FANSChange in Diastolic Blood Pressure From 6 Months to 12 Months5.20 mmHgStandard Deviation 20.15
TotalChange in Diastolic Blood Pressure From 6 Months to 12 Months1.95 mmHgStandard Deviation 18.82
Secondary

Change in Diastolic Blood Pressure From Baseline

Blood pressure is measured by study RAs after the patient is seated for 5 minutes, with the average of three readings used as the diastolic blood pressure for that visit.

Time frame: 6 Months

Population: 2 participants in active control arm did not attend follow up visit. Hba1c taken from medical records, no other data available. 2 participants refused BP measurement

ArmMeasureValue (MEAN)Dispersion
TExT-MED OnlyChange in Diastolic Blood Pressure From Baseline-0.27 mmHgStandard Deviation 17.11
TExT-MED+FANSChange in Diastolic Blood Pressure From Baseline-2.56 mmHgStandard Deviation 20.09
TotalChange in Diastolic Blood Pressure From Baseline-1.36 mmHgStandard Deviation 18.53
Secondary

Change in Fatalism From 6 Months to 12 Months

Fatalism is measured by the Diabetes Fatalism Scale (Egede & Ellis, 2010), which measures three subscale emotional distress, religiosity and coping and perceived self-efficacy, which are summed together. The total score ranges from 12-72, higher score indicates higher fatalism, and has a Cronbach's alpha of 0.80. The score is associated with glycemic control, depression, self-care behaviors and social factors.

Time frame: 12 Months

Population: 5 participants decline to answer questions

ArmMeasureValue (MEAN)Dispersion
TExT-MED OnlyChange in Fatalism From 6 Months to 12 Months-1.30 units on a scaleStandard Deviation 8.97
TExT-MED+FANSChange in Fatalism From 6 Months to 12 Months-1.20 units on a scaleStandard Deviation 8.51
TotalChange in Fatalism From 6 Months to 12 Months-1.26 units on a scaleStandard Deviation 8.7
Secondary

Change in Fatalism From Baseline

Fatalism is measured by the Diabetes Fatalism Scale (Egede & Ellis, 2010), which measures three subscale emotional distress, religiosity and coping and perceived self-efficacy, which are summed together. The total score ranges from 12-72, higher score indicates higher fatalism, and has a Cronbach's alpha of 0.80. The score is associated with glycemic control, depression, self-care behaviors and social factors.

Time frame: 6 Months

Population: 2 participants decline to answer questions. 2 participants in active control arm did not attend follow up visit. Hba1c taken from medical records, no other data available.

ArmMeasureValue (MEAN)Dispersion
TExT-MED OnlyChange in Fatalism From Baseline-1.44 units on a scaleStandard Deviation 9.47
TExT-MED+FANSChange in Fatalism From Baseline0.58 units on a scaleStandard Deviation 10.61
TotalChange in Fatalism From Baseline-0.47 units on a scaleStandard Deviation 10.03
Secondary

Change in HBA1c From 6 Months to 12 Months

Glycemic control is measured by hemoglobin A1C collected at point-of-care from an Afinion AS100 capillary point of care machine. The Afinion machine has excellent point of care correlation with laboratory values. As a surrogate for average glycemic control over the previous 3 months and with correlation with clinical outcomes, hemoglobin A1c is a marker of overall clinical disease management. Change is 6 month value minus 12 month value.

Time frame: 12 months

Population: 2 intervention group patient refused blood draw at follow up.

ArmMeasureValue (MEAN)
TExT-MED OnlyChange in HBA1c From 6 Months to 12 Months-.36 %mmHg/dL
TExT-MED+FANSChange in HBA1c From 6 Months to 12 Months.28 %mmHg/dL
Secondary

Change in Healthcare Utilization From 6 Months to 12 Months

Healthcare utilization by EMR review of clinic appointments, ED visits and hospitalizations within enrollment through 6 months at each follow up visit.

Time frame: 12 Months

Population: all patients initially enrolled in trial followed in EMR

ArmMeasureGroupValue (MEAN)Dispersion
TExT-MED OnlyChange in Healthcare Utilization From 6 Months to 12 MonthsED/UCC Visit0.07 Number of Healthcare EncountersStandard Deviation 1.35
TExT-MED OnlyChange in Healthcare Utilization From 6 Months to 12 MonthsClinic Visits Made1.10 Number of Healthcare EncountersStandard Deviation 4.3
TExT-MED OnlyChange in Healthcare Utilization From 6 Months to 12 MonthsHospitalization-.02 Number of Healthcare EncountersStandard Deviation 0.65
TExT-MED+FANSChange in Healthcare Utilization From 6 Months to 12 MonthsED/UCC Visit.05 Number of Healthcare EncountersStandard Deviation 1.57
TExT-MED+FANSChange in Healthcare Utilization From 6 Months to 12 MonthsHospitalization0 Number of Healthcare EncountersStandard Deviation 0.83
TExT-MED+FANSChange in Healthcare Utilization From 6 Months to 12 MonthsClinic Visits Made.88 Number of Healthcare EncountersStandard Deviation 6.3
TotalChange in Healthcare Utilization From 6 Months to 12 MonthsED/UCC Visit.06 Number of Healthcare EncountersStandard Deviation 1.46
TotalChange in Healthcare Utilization From 6 Months to 12 MonthsClinic Visits Made.99 Number of Healthcare EncountersStandard Deviation 5.34
TotalChange in Healthcare Utilization From 6 Months to 12 MonthsHospitalization-.01 Number of Healthcare EncountersStandard Deviation 0.74
Secondary

Change in Healthcare Utilization From Baseline

Healthcare utilization by EMR review of clinic appointments, ED visits and hospitalizations within enrollment through 6 months at each follow up visit.

Time frame: 6 Months

Population: 166 patients who initially enrolled followed in EMR

ArmMeasureGroupValue (MEAN)Dispersion
TExT-MED OnlyChange in Healthcare Utilization From BaselineHospitalization0.24 Number of Healthcare EncountersStandard Deviation 0.72
TExT-MED OnlyChange in Healthcare Utilization From BaselineED/UCC Visit1.47 Number of Healthcare EncountersStandard Deviation 1.87
TExT-MED OnlyChange in Healthcare Utilization From BaselineClinic Visits Made-.97 Number of Healthcare EncountersStandard Deviation 3.87
TExT-MED+FANSChange in Healthcare Utilization From BaselineHospitalization.13 Number of Healthcare EncountersStandard Deviation 0.96
TExT-MED+FANSChange in Healthcare Utilization From BaselineED/UCC Visit.88 Number of Healthcare EncountersStandard Deviation 2.22
TExT-MED+FANSChange in Healthcare Utilization From BaselineClinic Visits Made-2 Number of Healthcare EncountersStandard Deviation 6.45
TotalChange in Healthcare Utilization From BaselineED/UCC Visit1.18 Number of Healthcare EncountersStandard Deviation 2.06
TotalChange in Healthcare Utilization From BaselineClinic Visits Made-1.46 Number of Healthcare EncountersStandard Deviation 5.28
TotalChange in Healthcare Utilization From BaselineHospitalization.19 Number of Healthcare EncountersStandard Deviation 0.84
Secondary

Change in Norbeck Social Support Questionnaire From 6 Months to 12 Months

Measure Description: General social support is captured by the Norbeck Social Support Questionnaire Emotional and&Tangible subscales.(Norbeck, Lindsey, & Carrieri, 1981) General social support: Norbeck Social Support Questionnaire, emotional sub score (ranges 0-16, with higher scores indicating higher perceived emotional support) & tangible sub score (0-8, higher score indicating higher perceived tangible support). While the subscores are highly correlated, the authors do not recommend Cronbach's alpha as a test of internal validity.(http://eileengigliotti.com/uploads/1/1/0/2/110241155/nssq-psychometric.pdf)

Time frame: 12 Months

Population: 2 participants decline to answer question

ArmMeasureGroupValue (MEAN)Dispersion
TExT-MED OnlyChange in Norbeck Social Support Questionnaire From 6 Months to 12 MonthsTangible-0.36 units on a scaleStandard Deviation 2.17
TExT-MED OnlyChange in Norbeck Social Support Questionnaire From 6 Months to 12 MonthsEmotional-0.48 units on a scaleStandard Deviation 4.03
TExT-MED+FANSChange in Norbeck Social Support Questionnaire From 6 Months to 12 MonthsTangible0.48 units on a scaleStandard Deviation 2.08
TExT-MED+FANSChange in Norbeck Social Support Questionnaire From 6 Months to 12 MonthsEmotional0.69 units on a scaleStandard Deviation 4.01
TotalChange in Norbeck Social Support Questionnaire From 6 Months to 12 MonthsTangible0.02 units on a scaleStandard Deviation 2.16
TotalChange in Norbeck Social Support Questionnaire From 6 Months to 12 MonthsEmotional0.06 units on a scaleStandard Deviation 4.04
Secondary

Change in Norbeck Social Support Questionnaire From Baseline

Measure Description: General social support is captured by the Norbeck Social Support Questionnaire Emotional and&Tangible subscales.(Norbeck, Lindsey, & Carrieri, 1981) General social support: Norbeck Social Support Questionnaire, emotional sub score (ranges 0-16, with higher scores indicating higher perceived emotional support) & tangible sub score (0-8, higher score indicating higher perceived tangible support). While the subscores are highly correlated, the authors do not recommend Cronbach's alpha as a test of internal validity.(http://eileengigliotti.com/uploads/1/1/0/2/110241155/nssq-psychometric.pdf)

Time frame: 6 Months

Population: 10 participants decline to answer questions. 2 participants in active control arm did not attend follow up visit. Hba1c taken from medical records, no other data available.

ArmMeasureGroupValue (MEAN)Dispersion
TExT-MED OnlyChange in Norbeck Social Support Questionnaire From BaselineEmotional0.64 units on a scaleStandard Deviation 4.02
TExT-MED OnlyChange in Norbeck Social Support Questionnaire From BaselineTangible0.06 units on a scaleStandard Deviation 1.99
TExT-MED+FANSChange in Norbeck Social Support Questionnaire From BaselineEmotional-0.22 units on a scaleStandard Deviation 4.41
TExT-MED+FANSChange in Norbeck Social Support Questionnaire From BaselineTangible-0.29 units on a scaleStandard Deviation 2.02
TotalChange in Norbeck Social Support Questionnaire From BaselineEmotional0.24 units on a scaleStandard Deviation 4.2
TotalChange in Norbeck Social Support Questionnaire From BaselineTangible-0.10 units on a scaleStandard Deviation 2
Secondary

Change in Partner Distress Scale From Baseline

Supporter diabetes-related distress is measured by the Partner Distress Scale (Polonsky, Fisher, Hessler, &Johnson, 2016). The self-report scale consists of 21 items in 4 domains: my partner's diabetes management, how best to help, diabetes & me, & hypoglycemia. Domains are summed together. Each item is score from 0 to 4, lower scores indicate less distress. The total score is an average of the 21 items. The Cronbach's alpha was 0.76 for total scores. Greater partner distress is correlated with higher A1C among patients, worse self-care & lower satisfaction with relationship

Time frame: 6 Months

Population: Supporters who were reached for follow up at 6 months

ArmMeasureValue (MEAN)Dispersion
TExT-MED OnlyChange in Partner Distress Scale From Baseline.45 units on a scaleStandard Deviation 0.83
TExT-MED+FANSChange in Partner Distress Scale From Baseline.13 units on a scaleStandard Deviation 0.89
TotalChange in Partner Distress Scale From Baseline.37 units on a scaleStandard Deviation 0.89
Secondary

Change in Patient Health Questionnaire 9 From 6 Months to 12 Months

Depression as measured by the PHQ-9 (Kroenke, Spitzer, Williams, & Lowe, 2010), is a widely used scale of depression used in clinical practice and research. The Cronbach's alpha ranges from 0.86-0.89, and it has been validated in multiple languages. Depression is worse with higher scores. Score ranges from 0 to 27. Higher levels of depression are associated with fewer healthy behaviors and worse glycemic control.

Time frame: 12 Months

Population: 2 participants decline to answer questions

ArmMeasureValue (MEAN)Dispersion
TExT-MED OnlyChange in Patient Health Questionnaire 9 From 6 Months to 12 Months-0.18 units on a scaleStandard Deviation 6.86
TExT-MED+FANSChange in Patient Health Questionnaire 9 From 6 Months to 12 Months-0.13 units on a scaleStandard Deviation 5.17
TotalChange in Patient Health Questionnaire 9 From 6 Months to 12 Months-0.15 units on a scaleStandard Deviation 6.09
Secondary

Change in Patient Health Questionnaire 9 From Baseline

Depression as measured by the PHQ-9 (Kroenke, Spitzer, Williams, & Lowe, 2010), is a widely used scale of depression used in clinical practice and research. The Cronbach's alpha ranges from 0.86-0.89, and it has been validated in multiple languages. Depression is worse with higher scores. Score ranges from 0 to 27. Higher levels of depression are associated with fewer healthy behaviors and worse glycemic control.

Time frame: 6 Months

Population: 2 participants in active control arm did not attend follow up visit. Hba1c taken from medical records, no other data available. 1 participant decline to answer question

ArmMeasureValue (MEAN)Dispersion
TExT-MED OnlyChange in Patient Health Questionnaire 9 From Baseline3.86 units on a scaleStandard Error 6.19
TExT-MED+FANSChange in Patient Health Questionnaire 9 From Baseline2.33 units on a scaleStandard Error 6.2
TotalChange in Patient Health Questionnaire 9 From Baseline3.13 units on a scaleStandard Error 6.21
Secondary

Change in Summary of Diabetes Self-care Activities From 6 Months to 12 Months

Summary of Diabetes Self-care Activities (Toobert, Hampson, Glasgow, & RE, 2000). The Summary consists of 6 subscales representing different domains of diabetes related healthy behaviors and self-care. It has been validated in over 10 studies, with the results published in two manuscripts: one with three studies (Toobert & Glasgow, 1994), and one with seven studies(Toobert et al., 2000). Each measure ranges from Each range from 0-7, indicating number of days per week patient reports engaging in these behaviors.

Time frame: 12 Months

Population: one participant did not answer carb spacing as they did not know what that meant.

ArmMeasureGroupValue (MEAN)Dispersion
TExT-MED OnlyChange in Summary of Diabetes Self-care Activities From 6 Months to 12 MonthsFollowing a generally healthy diet0.23 units on a scaleStandard Deviation 2.5
TExT-MED OnlyChange in Summary of Diabetes Self-care Activities From 6 Months to 12 MonthsFollowing a disease specific diet plan0.29 units on a scaleStandard Deviation 1.85
TExT-MED OnlyChange in Summary of Diabetes Self-care Activities From 6 Months to 12 MonthsSelf-monitoring blood glucose as advised by a h-0.66 units on a scaleStandard Deviation 3.19
TExT-MED OnlyChange in Summary of Diabetes Self-care Activities From 6 Months to 12 MonthsChecking feet daily for wounds-0.81 units on a scaleStandard Deviation 2.64
TExT-MED OnlyChange in Summary of Diabetes Self-care Activities From 6 Months to 12 MonthsCarb Spacing carbohydrates throughout the day0.11 units on a scaleStandard Deviation 4.51
TExT-MED OnlyChange in Summary of Diabetes Self-care Activities From 6 Months to 12 MonthsGetting sufficient physical activity0.11 units on a scaleStandard Deviation 2.97
TExT-MED+FANSChange in Summary of Diabetes Self-care Activities From 6 Months to 12 MonthsGetting sufficient physical activity0.81 units on a scaleStandard Deviation 2.88
TExT-MED+FANSChange in Summary of Diabetes Self-care Activities From 6 Months to 12 MonthsFollowing a generally healthy diet0.96 units on a scaleStandard Deviation 2.74
TExT-MED+FANSChange in Summary of Diabetes Self-care Activities From 6 Months to 12 MonthsChecking feet daily for wounds0.01 units on a scaleStandard Deviation 1.93
TExT-MED+FANSChange in Summary of Diabetes Self-care Activities From 6 Months to 12 MonthsCarb Spacing carbohydrates throughout the day0.31 units on a scaleStandard Deviation 3.89
TExT-MED+FANSChange in Summary of Diabetes Self-care Activities From 6 Months to 12 MonthsFollowing a disease specific diet plan0.45 units on a scaleStandard Deviation 1.85
TExT-MED+FANSChange in Summary of Diabetes Self-care Activities From 6 Months to 12 MonthsSelf-monitoring blood glucose as advised by a h-0.18 units on a scaleStandard Deviation 2.4
TotalChange in Summary of Diabetes Self-care Activities From 6 Months to 12 MonthsFollowing a disease specific diet plan0.36 units on a scaleStandard Deviation 1.84
TotalChange in Summary of Diabetes Self-care Activities From 6 Months to 12 MonthsSelf-monitoring blood glucose as advised by a h-0.44 units on a scaleStandard Deviation 2.84
TotalChange in Summary of Diabetes Self-care Activities From 6 Months to 12 MonthsGetting sufficient physical activity0.43 units on a scaleStandard Deviation 2.94
TotalChange in Summary of Diabetes Self-care Activities From 6 Months to 12 MonthsChecking feet daily for wounds-0.43 units on a scaleStandard Deviation 2.36
TotalChange in Summary of Diabetes Self-care Activities From 6 Months to 12 MonthsFollowing a generally healthy diet0.57 units on a scaleStandard Deviation 2.62
TotalChange in Summary of Diabetes Self-care Activities From 6 Months to 12 MonthsCarb Spacing carbohydrates throughout the day0.20 units on a scaleStandard Deviation 4.22
Secondary

Change in Summary of Diabetes Self-care Activities From Baseline

Summary of Diabetes Self-care Activities (Toobert, Hampson, Glasgow, & RE, 2000). The Summary consists of 6 subscales representing different domains of diabetes related healthy behaviors and self-care. It has been validated in over 10 studies, with the results published in two manuscripts: one with three studies (Toobert & Glasgow, 1994), and one with seven studies(Toobert et al., 2000). Each measure ranges from Each range from 0-7, indicating number of days per week patient reports engaging in these behaviors.

Time frame: 6 Months

Population: 2 participants in active control arm did not attend follow up visit. Hba1c taken from medical records, no other data available.

ArmMeasureGroupValue (MEAN)Dispersion
TExT-MED OnlyChange in Summary of Diabetes Self-care Activities From BaselineFollowing a generally healthy diet-1.55 units on a scaleStandard Deviation 2.91
TExT-MED OnlyChange in Summary of Diabetes Self-care Activities From BaselineFollowing a disease specific diet plan-0.42 units on a scaleStandard Deviation 2.12
TExT-MED OnlyChange in Summary of Diabetes Self-care Activities From BaselineSelf-monitoring blood glucose as advised by a h-0.91 units on a scaleStandard Deviation 3
TExT-MED OnlyChange in Summary of Diabetes Self-care Activities From BaselineChecking feet daily for wounds-1.25 units on a scaleStandard Deviation 2.96
TExT-MED OnlyChange in Summary of Diabetes Self-care Activities From BaselineSpacing carbohydrates throughout the day-0.71 units on a scaleStandard Deviation 4.34
TExT-MED OnlyChange in Summary of Diabetes Self-care Activities From BaselineGetting sufficient physical activity-0.39 units on a scaleStandard Deviation 2.99
TExT-MED+FANSChange in Summary of Diabetes Self-care Activities From BaselineGetting sufficient physical activity-0.90 units on a scaleStandard Deviation 3.14
TExT-MED+FANSChange in Summary of Diabetes Self-care Activities From BaselineFollowing a generally healthy diet-1.17 units on a scaleStandard Deviation 2.69
TExT-MED+FANSChange in Summary of Diabetes Self-care Activities From BaselineChecking feet daily for wounds-1.36 units on a scaleStandard Deviation 2.69
TExT-MED+FANSChange in Summary of Diabetes Self-care Activities From BaselineSpacing carbohydrates throughout the day-0.20 units on a scaleStandard Deviation 3.31
TExT-MED+FANSChange in Summary of Diabetes Self-care Activities From BaselineFollowing a disease specific diet plan-0.78 units on a scaleStandard Deviation 1.93
TExT-MED+FANSChange in Summary of Diabetes Self-care Activities From BaselineSelf-monitoring blood glucose as advised by a h-0.10 units on a scaleStandard Deviation 2.84
TotalChange in Summary of Diabetes Self-care Activities From BaselineFollowing a disease specific diet plan-0.59 units on a scaleStandard Deviation 2.03
TotalChange in Summary of Diabetes Self-care Activities From BaselineSelf-monitoring blood glucose as advised by a h-0.53 units on a scaleStandard Deviation 2.94
TotalChange in Summary of Diabetes Self-care Activities From BaselineGetting sufficient physical activity-0.63 units on a scaleStandard Deviation 3.06
TotalChange in Summary of Diabetes Self-care Activities From BaselineChecking feet daily for wounds-1.30 units on a scaleStandard Deviation 2.83
TotalChange in Summary of Diabetes Self-care Activities From BaselineFollowing a generally healthy diet-1.37 units on a scaleStandard Deviation 2.8
TotalChange in Summary of Diabetes Self-care Activities From BaselineSpacing carbohydrates throughout the day-0.47 units on a scaleStandard Deviation 3.89
Secondary

Change in Systolic Blood Pressure From 6 Months to 12 Months

Blood pressure is measured by study RAs after the patient is seated for 5 minutes, with the average of three readings used as the systolic blood pressure for that visit. Systolic blood pressure is associated with cardiovascular complications

Time frame: 12 Months

Population: 11 patients with SBP unable to be obtained

ArmMeasureValue (MEAN)Dispersion
TExT-MED OnlyChange in Systolic Blood Pressure From 6 Months to 12 Months-4.95 mmHgStandard Deviation 31.81
TExT-MED+FANSChange in Systolic Blood Pressure From 6 Months to 12 Months2.09 mmHgStandard Deviation 37.46
TotalChange in Systolic Blood Pressure From 6 Months to 12 Months-1.71 mmHgStandard Deviation 34.47
Secondary

Change in Systolic Blood Pressure From Baseline

Blood pressure is measured by study RAs after the patient is seated for 5 minutes, with the average of three readings used as the systolic blood pressure for that visit. Systolic blood pressure is associated with cardiovascular complications

Time frame: 6 Months

Population: 2 participants in active control arm did not attend follow up visit. Hba1c taken from medical records, no other data available. 2 participants refused BP measurement

ArmMeasureValue (MEAN)Dispersion
TExT-MED OnlyChange in Systolic Blood Pressure From Baseline-9.11 mmHgStandard Deviation 30.45
TExT-MED+FANSChange in Systolic Blood Pressure From Baseline-13.07 mmHgStandard Deviation 36.34
TotalChange in Systolic Blood Pressure From Baseline-11.00 mmHgStandard Deviation 33.28
Secondary

Change in WHO Quality of Life From 6 Months to 12 Months

Quality of life (World Health Organization WHO-5 Well Being Index) (Topp, Ostergaard, Sondergaard, & Bech, 2015) is a widely used measure of quality life, validated in many languages and consists of only 5 items. Each self-reported item is scored between 0 and 5, summed together and then multiplied by 4. The total range is from 0 to 100, with 0 being the lowest quality of life.

Time frame: 12 Months

ArmMeasureValue (MEAN)Dispersion
TExT-MED OnlyChange in WHO Quality of Life From 6 Months to 12 Months0.09 units on a scaleStandard Deviation 34.02
TExT-MED+FANSChange in WHO Quality of Life From 6 Months to 12 Months6.30 units on a scaleStandard Deviation 29.9
TotalChange in WHO Quality of Life From 6 Months to 12 Months2.94 units on a scaleStandard Deviation 32.16
Secondary

Change in WHO Quality of Life From Baseline

Quality of life (World Health Organization WHO-5 Well Being Index) (Topp, Ostergaard, Sondergaard, & Bech, 2015) is a widely used measure of quality life, validated in many languages and consists of only 5 items. Each self-reported item is scored between 0 and 5, summed together and then multiplied by 4. The total range is from 0 to 100, with 0 being the lowest quality of life.

Time frame: 6 Months

Population: 2 participants in active control arm did not attend follow up visit. Hba1c taken from medical records, no other data available.

ArmMeasureValue (MEAN)Dispersion
TExT-MED OnlyChange in WHO Quality of Life From Baseline-9.69 units on a scaleStandard Deviation 31.47
TExT-MED+FANSChange in WHO Quality of Life From Baseline-4.96 units on a scaleStandard Deviation 29.86
TotalChange in WHO Quality of Life From Baseline-7.47 units on a scaleStandard Deviation 30.66
Secondary

Change in Wilson 3 Item Scale From 6 Months to 12 Months

Medication adherence(Wilson et al.,2014). The 3item medication adherence scale is a self-report measure that assessing no. of days medication missed in prior month, days taken medication as advised & self-rated medication adherence. Developed in HIV research, it has been validated for non-HIV medications (Wilson, et al,2016). Each component contributes 33% of the scale. Total score ranges from 0-100. It is the combination of 3 sub-scores, (days missed dose(negative scored), self-rating, days taking medications as indicated). Higher scores indicate better medication adherence.

Time frame: 12 Months

Population: 1 Participant decline to answer question

ArmMeasureValue (MEAN)Dispersion
TExT-MED OnlyChange in Wilson 3 Item Scale From 6 Months to 12 Months1.74 units on a scaleStandard Deviation 18.92
TExT-MED+FANSChange in Wilson 3 Item Scale From 6 Months to 12 Months3.22 units on a scaleStandard Deviation 22.89
TotalChange in Wilson 3 Item Scale From 6 Months to 12 Months2.43 units on a scaleStandard Deviation 20.75
Secondary

Change in Wilson 3 Item Scale From Baseline

Medication adherence(Wilson et al.,2014). The 3item medication adherence scale is a self-report measure that assessing no. of days medication missed in prior month, days taken medication as advised & self-rated medication adherence. Developed in HIV research, it has been validated for non-HIV medications (Wilson, et al,2016). Each component contributes 33% of the scale. Total score ranges from 0-100. It is the combination of 3 sub-scores, (days missed dose(negative scored), self-rating, days taking medications as indicated). Higher scores indicate better medication adherence.

Time frame: 6 Months

Population: 2 participants in active control arm did not attend follow up visit. Hba1c taken from medical records, no other data available.

ArmMeasureValue (MEAN)Dispersion
TExT-MED OnlyChange in Wilson 3 Item Scale From Baseline-15.73 units on a scaleStandard Deviation 30.87
TExT-MED+FANSChange in Wilson 3 Item Scale From Baseline-12.39 units on a scaleStandard Deviation 31.11
TotalChange in Wilson 3 Item Scale From Baseline-14.16 units on a scaleStandard Deviation 30.87

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026